Therapeutic Neovascularization–Quo Vadis?

1. Clinical Vascular Growth Factor Therapy for Neovascularization in Patients with Coronary Artery Disease
Jens Kastrup

2. The Strengths and Weaknesses of VEGF Adenovirus-Driven Angiogenesis
Petra Korpisalo, Tuomas T. Rissanen, Seppo Ylä-Herttuala

3. Angiogenesis and Arteriogenesis in Diabetes Mellitus: Signal Transduction Defects as the Molecular Basis of Vascular Cell Dysfunction
Vadim Tchaikovski, Johannes Waltenberger

4. Endothelial Activation and Neointimal Hyperplasia: A Double-Edged Sword
R. Khurana, M. Simons

5. Pampering and Priming the Heart
M.J. Post, R.N.M. Cornelussen, F.W. Prinzen

6. Coronary Venous Retroinfusion: A Novel Venue of Regional Induction of Neovascularization
Peter Boekstegers, Christian Kupatt

7. Integrative Pro-angiogenic Activation: HIF-?
Karen A. Vincent, Ralph A. Kelly

8. The Maturation of Vessels – A Limitation to Forced Neovascularization?
A. Banfi, P. Fueglistaler, R. Gianni-Barrera

9. Vascular and Neuronal Development: Intersecting Parallelisms and rossroads
Serena Zacchigna, Carmen Ruiz Almodovar, Peggy Lafuste, Peter Carmeliet

10. Cathelicidin Antimicrobial Peptides Modulate Angiogenesis
Rembert Koczulla, Robert Bals

11. The Biology of Embryonic and Adult Endothelial Progenitor Cells
Mathias Lamparter, Antonis K. Hatzopoulos

12. Signaling Behind Progenitor Cell Mobilization: Focus on Enos and Caveolin
Olivier Feron

13. The Role of Monocytes/Macrophages and Vascular Resident Precursor Cells in Collateral Growth
Wulf D. Ito

Nyckelord: Biomedicine, Molecular Medicine, Cardiology, Medical Biochemistry, Cancer Research